A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2018
Price : $35 *
At a glance
- Drugs Relenopride (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors SK Life Science
- 18 Dec 2014 Status changed from active, no longer recruiting to completedas reported by ClinicalTrials.gov record.
- 02 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 26 Nov 2013 New trial record